Related references
Note: Only part of the references are listed.The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial
Yukari Shirasugi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review
Yoshiyuki Kurata et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Long-term efficacy of Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study
C. Tsumoto et al.
ANNALS OF HEMATOLOGY (2009)
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
James B. Bussel et al.
BLOOD (2009)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
The ITP syndrome: pathogenic and clinical diversity
Douglas B. Cines et al.
BLOOD (2009)
Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production
Diane Nugent et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review
Donald M. Arnold et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura
Yukari Shirasugi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:: a double-blind randomised controlled trial
David J. Kuter et al.
LANCET (2008)
Does Helicobacter pylori Eradication Therapy Result in a Platelet Count Improvement in Adults with Immune Thrombocytopenic Purpura Regardless of H pylori Infection?
D. M. Arnold et al.
Hematology-American Society of Hematology Education Program (2008)
Pharmacodynamics and pharmacokinetics of AMG 531, a thrombopoiesis-stimulating peptibody, in healthy Japanese subjects: A randomized, placebo-controlled study
Yuji Kumagai et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
The pathogenesis of chronic immune thrombocytopenic purpura
Robert McMillan
SEMINARS IN HEMATOLOGY (2007)
Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics
Shalini Gupta et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Helicobacter pylori and immune thrombocytopenic purpura:: Unsolved questions and controversies
Masataka Kuwana et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura -: A randomized controlled trial
T Suzuki et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura?: Analysis of 207 eradicated chronic ITP cases in Japan
K Fujimura et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
Management of immune thrombocytopenic purpura in adults
R Stasi et al.
MAYO CLINIC PROCEEDINGS (2004)
Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products
AR Mire-Sluis et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Validation of the BIACORE 3000 platform for detection of antibodies against erythropoietic agents in human serum samples
S Mason et al.
CURRENT MEDICAL RESEARCH AND OPINION (2003)
Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura
S Nomura et al.
BLOOD (2002)
Share Paper
